These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 17126204)

  • 21. Mathematical model for evaluating incidence of acute rectal toxicity during conventional or hypofractionated radiotherapy courses for prostate cancer.
    Strigari L; Arcangeli G; Arcangeli S; Benassi M
    Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1454-60. PubMed ID: 18990503
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prostate cancer: biological dose considerations and constraints in tele- and brachytherapy.
    Dörr W; Jaal J; Zips D
    Strahlenther Onkol; 2007 Dec; 183 Spec No 2():14-5. PubMed ID: 18166999
    [No Abstract]   [Full Text] [Related]  

  • 23. Endoscopic treatment of chronic radiation proctopathy.
    Wilson SA; Rex DK
    Curr Opin Gastroenterol; 2006 Sep; 22(5):536-40. PubMed ID: 16891886
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anorectal injury following pelvic radiotherapy.
    Hayne D; Vaizey CJ; Boulos PB
    Br J Surg; 2001 Aug; 88(8):1037-48. PubMed ID: 11488787
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of a radiation-induced rectal ulcer with hyperbaric oxygen therapy in a man with prostate cancer.
    Nakabayashi M; Beard C; Kelly SM; Carr-Locke DL; Oh WK
    Urol Oncol; 2006; 24(6):503-8. PubMed ID: 17138131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toxicity and health-related quality-of-life assessment in prostate radiotherapy.
    Rodrigues G; Lock M; D'Souza D
    Can J Urol; 2007 Aug; 14(4):3608-15. PubMed ID: 17784980
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Late rectal and urinary toxicity from conformal, dose-escalated radiation therapy for prostate cancer: a prospective study of 402 patients.
    Lin C; Turner S; Mai T; Kneebone A; Gebski V
    Australas Radiol; 2007 Dec; 51(6):578-83. PubMed ID: 17958696
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bladder and rectal toxicity of BeamCath application in radiotherapy of prostate cancer.
    Hanssen S; Norum J
    Anticancer Res; 2008; 28(5B):2865-8. PubMed ID: 19031926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rectal morbidity following I-125 prostate brachytherapy in relation to dosimetry.
    Ohashi T; Yorozu A; Toya K; Saito S; Momma T; Nagata H; Kosugi M
    Jpn J Clin Oncol; 2007 Feb; 37(2):121-6. PubMed ID: 17255159
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-dose external beam radiation for localized prostate cancer: current status and future challenges.
    Nguyen PL; Zietman AL
    Cancer J; 2007; 13(5):295-301. PubMed ID: 17921728
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rectourethral fistula after combination radiotherapy for prostate cancer.
    Marguet C; Raj GV; Brashears JH; Anscher MS; Ludwig K; Mouraviev V; Robertson CN; Polascik TJ
    Urology; 2007 May; 69(5):898-901. PubMed ID: 17482930
    [TBL] [Abstract][Full Text] [Related]  

  • 32. To bleed or not to bleed. A prediction based on individual gene profiling combined with dose-volume histogram shapes in prostate cancer patients undergoing three-dimensional conformal radiation therapy.
    Valdagni R; Rancati T; Ghilotti M; Cozzarini C; Vavassori V; Fellin G; Fiorino C; Girelli G; Barra S; Zaffaroni N; Pierotti MA; Gariboldi M
    Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1431-40. PubMed ID: 19211196
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation between dosimetric parameters and late rectal and urinary toxicities in patients treated with high-dose-rate brachytherapy used as monotherapy for prostate cancer.
    Konishi K; Yoshioka Y; Isohashi F; Sumida I; Kawaguchi Y; Kotsuma T; Adachi K; Morimoto M; Fukuda S; Inoue T
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1003-7. PubMed ID: 19345517
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rectal dose reduction using three-dimensional conformal radiotherapy for locally advanced prostate cancer: A combination of conformal dynamic-arc and five-static field technique.
    Sasaoka M; Nishikawa A; Futami T; Nishida K; Miwa H; Kadoya K
    Radiother Oncol; 2009 Mar; 90(3):318-24. PubMed ID: 19008004
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patient-assessed late toxicity rates and principal component analysis after image-guided radiation therapy for prostate cancer.
    Skala M; Rosewall T; Dawson L; Divanbeigi L; Lockwood G; Thomas C; Crook J; Chung P; Warde P; Catton C
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):690-8. PubMed ID: 17379434
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationships between rectal wall dose-volume constraints and radiobiologic indices of toxicity for patients with prostate cancer.
    Marzi S; Arcangeli G; Saracino B; Petrongari MG; Bruzzaniti V; Iaccarino G; Landoni V; Soriani A; Benassi M
    Int J Radiat Oncol Biol Phys; 2007 May; 68(1):41-9. PubMed ID: 17276615
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypofractionated accelerated radiotherapy using concomitant intensity-modulated radiotherapy boost technique for localized high-risk prostate cancer: acute toxicity results.
    Lim TS; Cheung PC; Loblaw DA; Morton G; Sixel KE; Pang G; Basran P; Zhang L; Tirona R; Szumacher E; Danjoux C; Choo R; Thomas G
    Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):85-92. PubMed ID: 18355982
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Absence of ischemia in telangiectasias of chronic radiation proctopathy.
    Friedland S; Benaron D; Maxim P; Parachikov I; Soetikno R
    Endoscopy; 2006 May; 38(5):488-92. PubMed ID: 16767584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiation dose predicts for biochemical control in intermediate-risk prostate cancer patients treated with low-dose-rate brachytherapy.
    Ho AY; Burri RJ; Cesaretti JA; Stone NN; Stock RG
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):16-22. PubMed ID: 19289266
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intensity-modulated radiation therapy dose prescription, recording, and delivery: patterns of variability among institutions and treatment planning systems.
    Das IJ; Cheng CW; Chopra KL; Mitra RK; Srivastava SP; Glatstein E
    J Natl Cancer Inst; 2008 Mar; 100(5):300-7. PubMed ID: 18314476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.